Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1969 Dec;44(238):761–764. doi: 10.1136/adc.44.238.761

Fibrin-fibrinogen degradation products in sera of normal infants and children.

W S Uttley, A G Allan, J D Cash
PMCID: PMC2020358  PMID: 5356984

Full text

PDF
761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABALLI A. J., DE LAMERENS S. Coagulation changes in the neonatal period and in early infancy. Pediatr Clin North Am. 1962 Aug;9:785–817. doi: 10.1016/s0031-3955(16)31311-6. [DOI] [PubMed] [Google Scholar]
  2. ALKJAERSIG N., FLETCHER A. P., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization. J Clin Invest. 1962 Apr;41:917–934. doi: 10.1172/JCI104547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. AMBRUS C. M., WEINTRAUB D. H., DUNPHY D., DOWD J. E., PICKREN J. W., NISWANDER K. R., AMBRUS J. L. Studies on hyaline membrane disease. I. The fibrinolysin system in pathogenesis and therapy. Pediatrics. 1963 Jul;32:10–24. [PubMed] [Google Scholar]
  4. ASTRUP T. The biological significance of fibrinolysis. Lancet. 1956 Sep 15;271(6942):565–568. doi: 10.1016/s0140-6736(56)92048-7. [DOI] [PubMed] [Google Scholar]
  5. BOYDEN S. V. The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera. J Exp Med. 1951 Feb;93(2):107–120. doi: 10.1084/jem.93.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Benz J. J. Clotting factors and fibrinogen split products in the extravasular space. Thromb Diath Haemorrh. 1968 Mar 31;19(1):226–235. [PubMed] [Google Scholar]
  7. Bonifaci E., Baggio P., Gravina E. Demonstration of split products of fibrinogen in the blood of normal newborns. Biol Neonat. 1968;12(1):29–34. doi: 10.1159/000240088. [DOI] [PubMed] [Google Scholar]
  8. Boyd J. F. Disseminated fibrin thromboembolism among neonates dying within 48 hours of birth. Arch Dis Child. 1967 Aug;42(224):401–409. doi: 10.1136/adc.42.224.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Das P. C., Allan A. G., Woodfield D. G., Cash J. D. Fibrin degradation products in sera of normal subjects. Br Med J. 1967 Dec 23;4(5581):718–720. doi: 10.1136/bmj.4.5581.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dubber A. H., McNicol G. P., Uttley D., Douglas A. S. In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor. Br J Haematol. 1968 Jan;14(1):31–49. doi: 10.1111/j.1365-2141.1968.tb01470.x. [DOI] [PubMed] [Google Scholar]
  11. ELLIS B. C., STRANSKY A. A quick and accurate method for the determination of fibronogen in plasma. J Lab Clin Med. 1961 Sep;58:477–488. [PubMed] [Google Scholar]
  12. HAMMOND J. D., VEREL D. Observations on the distribution and biological half-life of human fibrinogen. Br J Haematol. 1959 Oct;5:431–438. doi: 10.1111/j.1365-2141.1959.tb04053.x. [DOI] [PubMed] [Google Scholar]
  13. KOWALSKI E., BUDZYNSKI A. Z., KOPEC M., LATALLO Z. S., LIPINSKI B., WEGRZYNOWICZ Z. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS. Thromb Diath Haemorrh. 1964 Oct 15;12:69–86. [PubMed] [Google Scholar]
  14. LITTLE J. R. Purpura fulminans treated successfully with anticoagulation; report of a case. J Am Med Assoc. 1959 Jan 3;169(1):36–40. doi: 10.1001/jama.1959.73000180007009b. [DOI] [PubMed] [Google Scholar]
  15. MCKAY D. G., WAHLE G. H., Jr Epidemic gastroenteritis due to Escherichia coli O111 B4. II. Pathologic anatomy, with special reference of the presence of the local and generalized Shwartzman phenomena. AMA Arch Pathol. 1955 Dec;60(6):679–693. [PubMed] [Google Scholar]
  16. McGehee W. G., Rapaport S. I., Hjort P. F. Intravascular coagulation in fulminant meningococcemia. Ann Intern Med. 1967 Aug;67(2):250–260. doi: 10.7326/0003-4819-67-2-250. [DOI] [PubMed] [Google Scholar]
  17. McKay D. G., Müller-Berghaus G. Therapeutic implications of disseminated intravascular coagulation. Am J Cardiol. 1967 Sep;20(3):392–410. doi: 10.1016/0002-9149(67)90063-x. [DOI] [PubMed] [Google Scholar]
  18. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  19. Murakami M., Sekimoto H., Yasuda Y., Masuda S., Motoda T. [A new method for the determination of fibrinolytic activity by means of immunoassay of breakdown products of fibrin and fibrinogen]. Rinsho Byori. 1965 Oct;13(10):542–548. [PubMed] [Google Scholar]
  20. NIEWIAROWSKI S., LATALLO Z., STACHURSKA J. Apparition d'un inhibiteur de la thromboplastinoformation au cours de la protéolyse du fibrinogène. Rev Hematol. 1959 Apr-Jun;14(2):118–128. [PubMed] [Google Scholar]
  21. Stark C. R., Abramson D., Erkan V. Intravascular coagulation and hyaline-membrane disease of the newborn. Lancet. 1968 Jun 1;1(7553):1180–1181. doi: 10.1016/s0140-6736(68)91871-0. [DOI] [PubMed] [Google Scholar]
  22. Stiehm E. R., Clatanoff D. V. Split products of fibrin in the serum of newborns. Pediatrics. 1969 May;43(5):770–780. [PubMed] [Google Scholar]
  23. TAYLOR K. B., WRIGHT F. W. Purpura gangrenosa. Lancet. 1956 Aug 11;271(6937):284–286. doi: 10.1016/s0140-6736(56)92084-0. [DOI] [PubMed] [Google Scholar]
  24. Wardle E. N. Haemorrhage and clotting state in the newborn. Lancet. 1968 Mar 30;1(7544):691–691. doi: 10.1016/s0140-6736(68)92129-6. [DOI] [PubMed] [Google Scholar]
  25. Woodfield D. G., Cole S. K., Allan A. G., Cash J. D. Serum fibrin degradation products throughout normal pregnancy. Br Med J. 1968 Dec 14;4(5632):665–668. doi: 10.1136/bmj.4.5632.665. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES